Spironolactone Therapy for Hidradenitis Suppurativa

    October 2019 in “ Clinical and Experimental Dermatology ”
    Catherine Quinlan, Brian Kirby, Rosalind Hughes
    Studysummary This study found that spironolactone significantly reduced pain, lesion count, and disease severity in patients with hidradenitis suppurativa, as reported in multiple patient cohorts.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data American Journal of Clinical Dermatology · 2019
    2. Antiandrogen Therapy with Spironolactone for the Treatment of Hidradenitis Suppurativa Journal of The American Academy of Dermatology · 2018
    3. Hormonal Therapies for Hidradenitis Suppurativa: A Review Dermatology online journal · 2017
    4. A Case Series of 20 Women with Hidradenitis Suppurativa Treated with Spironolactone Australasian Journal of Dermatology · 2015
    5. Spironolactone in Dermatological Treatments Der Hautarzt · 2013